Search

Jonathan Havens, Esq. and Qiara Butler provide a Foreword with historical context regarding the cannabis industry in Maryland. Jonathan Havens is a partner at Saul Ewing LLP, where he serves as co-chair of both the firm’s Cannabis Law Practice and its Food, Beverage & Agribusiness Practice, as well...

“[I]ndustry can move a lot quicker than Washington can. That’s always been the case. But it would be good if there was more clarity from Congress on a lot of these [hemp-related] issues. And, unfortunately, until you have a debated and negotiated Farm Bill, [the 2018 version is] just going to carry...

In a Bloomberg article titled, “Cannabis Industry Enjoys a Rare Moment of Progress,” Partner Zachary Kobrin discussed the implications of last week’s news that the U.S. Department of Health and Human Services is recommending looser restrictions for cannabis producers. Kobrin, who is based in Fort...

In a recent letter to the Drug Enforcement Administration (DEA), the Department of Health and Human Services (HHS) recommended that cannabis be reclassified as a Schedule III drug under the Controlled Substances Act. The DEA will conduct its own review of HHS’s findings before officially determining...

Financial services giant Mastercard banned the use of its debit cards for the purchase of state-legal cannabis. In an interview with Forbes, cannabis law attorney and partner Zack Kobrin says Mastercard’s actions are understandably motivated by the legal limbo that the cannabis industry exists in...

Zack Kobrin, cannabis law attorney and partner, tells The Recorder’s “Higher Law” that while Mastercard’s decision last week to ban the use of its debit cards in the state-legal purchase of marijuana is a blow to the cannabis industry, it will simply lead to new workarounds. “On a larger scale, yes...